Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Newave Pharmaceutical Inc

Clinical trials sponsored by Newave Pharmaceutical Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for tough blood cancers: LP-118 trial launches Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Completed 1

New pill shows promise for tough blood cancers in early trial

Disease control Completed

This early-phase study tested an experimental oral drug called LP-108, given alone or with another drug (azacitidine), in 32 adults with blood cancers (MDS, CMML, or AML) that returned or didn't respond to prior therapy. The main goals were to find the safest dose and understand …

Phase 1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC